作者: Elisa Giani , Andrea Enzo Scaramuzza , Gian Vincenzo Zuccotti
关键词:
摘要: Technologies for diabetes management, such as continuous subcutaneous insulin infusion (CSII) and glucose monitoring (CGM) systems, have improved remarkably over the last decades. These developments are impacting capacity to achieve recommended hemoglobin A1c levels assisting in preventing development progression of micro- macro vascular complications. While improvements metabolic control decreases risk severe moderate hypoglycemia been described with use these technologies, large epidemiological international studies show that many patients still unable meet their glycemic goals, even when technologies used. This editorial will review impact technology on control, quality life children youth type 1 diabetes. reviewed include CSII, CGM systems sensor-augmented pumps. In addition, usefulness advanced functions bolus profiles, calculators threshold-suspend features be also discussed. Moreover, current explore challenges using technologies. Indeed, despite evidence currently available potential benefits report barriers them. Finally this article highlight importance future tailored toward overcome optimizing avoiding hypoglycemia.